Product
Immunosuppressive
1 clinical trial
3 indications
Indication
Single TransplantIndication
5 years of follow-up after transplantClinical trial
De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression WithdrawalStatus: Completed, Estimated PCD: 2022-02-01